PharmStockPharmacy Stock

Inspra
Inspra

4.26
For patients managing blood pressure and heart conditions, this generic medicine blocks mineralocorticoid receptors to ease blood flow.
Ingredient
Eplerenone
Category
Heart & Blood Pressure
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Eplerenone
Reference Brand
Eplerenone
Product Origin
Generic Alternative
Reference Manufacturer
Pfizer
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antihypertensives
Product Category
Aldosterone Receptor Antagonist
Pharmacological Class
Potassium-Sparing Diuretic
Manufacturer Description
Developed to mitigate heart failure progression to support ventricular recovery and target mineralocorticoid activity.
Mechanism of Action
Selectively binds to mineralocorticoid receptors, preventing aldosterone from promoting sodium retention and myocardial fibrosis.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12–24 hours
Contraindications
Hyperkalemia, Severe renal failure, Concurrent strong CYP3A4 inhibitors
Severe Adverse Events
Severe hyperkalemia — requires immediate medical attention
Common Side Effects
Headache, Dizziness, Nausea
Uncommon Side Effects
Hyperkalemia, Electrolyte imbalance, Fatigue
Drug Interactions
Ketoconazole, Potassium Supplements, ACE Inhibitors
Pregnancy Safety Warnings
TGA Category B: Safety established in animal studies. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Aldactone
Information related to Inspra is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Insomnia Treatment - Lunesta Generic